Healthcare Contract Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type, By Process Type, By End User, and By Region – Market Forecast, 2025–2034

The healthcare contract manufacturing market size is expected to reach USD 625.55 Billion by 2034, according to a new study by Polaris Market Research. The report “Healthcare Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Type, By Process Type, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Healthcare contract manufacturing involves outsourcing drug and medical device production to specialized organizations, ensuring high-quality, cost-effective, and timely delivery. It is widely used in pharmaceuticals, biologics, and medical device production

The market growth is driven by rising demand for chronic disease treatments, increasing outsourcing of drug production, expansion of pharmaceutical and biotechnology industries, and growing adoption of advanced manufacturing technologies.

Healthcare Contract Manufacturing Market Report Highlights

Based on type, the pharmaceutical segment held the largest share in 2024 due to high demand for chronic disease drugs and biologics.

In terms of process type, formulation development led in 2024 due to the need for consistent and high-quality drug products.

Based on end user, pharmaceutical companies accounted for the largest market share in 2024 driven by high outsourcing demand and regulatory compliance requirements.

North America held the largest share in 2024, fueled by established pharmaceutical and biotechnology industries and advanced manufacturing infrastructure.

Asia Pacific witnessed the fastest growth due to expanding pharma industries, government incentives, and cost-effective manufacturing capabilities.

A few global key market players include Lonza Group, Catalent, Inc., Samsung Biologics Co., Ltd., WuXi Biologics, Thermo Fisher Scientific Inc., Recipharm AB, Boehringer Ingelheim International GmbH, Pfizer Inc., AGC Biologics, Jabil Inc., Novartis AG., Integer Holdings Corporation, Freudenberg Medical, Sterling Industries, Tegra Medical, and Scapa Healthcare.

Request a free sample copy or read the full market insights : healthcare contract manufacturing report

Polaris Market Research has segmented the market report on the basis of type, process type, end user, and region:

By Type (Revenue, USD Billion, 2020–2034)

Medical Devices

Therapeutic Area

Oncology

Infectious Diseases

Neurological Disorders

Cardiovascular Disease

Metabolic Disorders

Autoimmune Diseases

Respiratory Diseases

Ophthalmology

Gastrointestinal Disorders

Hormonal Disorders

Hematological Disorders

Others

Service

Accessories manufacturing

Assembly manufacturing

Component manufacturing

Device manufacturing

Pharmaceutical

API/Bulk Drugs

Advanced drug delivery formulations

Packaging

Finished dose formulations

Solid

Liquid

Semi-solid formulations

By Process Type (Revenue, USD Billion, 2020–2034)

Formulation Development

Packaging Solutions

Manufacturing Services

By End User (Revenue, USD Billion, 2020–2034)

Pharmaceutical Companies

Biotechnology Firms

Medical Device Companies

Research Institutions

By Region (Revenue, USD Billion, 2020–2034)

North America

The U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherland

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Latin America

Saudi Arabia

UAE

South Africa

Israel

Rest of South Africa Show more